Natera Inc (NAS:NTRA)
$ 162.39 0.4 (0.25%) Market Cap: 21.44 Bil Enterprise Value: 20.99 Bil PE Ratio: 0 PB Ratio: 22.95 GF Score: 70/100

Natera Inc at Canaccord Genuity Growth Conference Transcript

Aug 10, 2022 / 03:30PM GMT
Release Date Price: $55.29 (+8.80%)
Kyle Alexander Mikson
Canaccord Genuity Corp., Research Division - Analyst

Good morning, everyone, to the 42nd Annual Canaccord Genuity Global Growth Conference. I'm Kyle Mikson, Life Sciences and Diagnostics at Canaccord, and we are pleased to present Natera here today. Natera is a leader in cell-free DNA-based testing across women's health, oncology and organ health. And with us from the company we have Steve Chapman, CEO; Mike Brophy, CFO. Thanks, guys, for joining us today.

Steven Leonard Chapman
Natera, Inc. - CEO, President & Director

Sure. Thanks for having us.

Michael B. Brophy
Natera, Inc. - CFO

Yes. Thank you.

Questions & Answers

Kyle Alexander Mikson
Canaccord Genuity Corp., Research Division - Analyst

Awesome. So you reported the second quarter results last Thursday, I believe. Great results, I think, almost $200 billion of revenue, solid results across the board. Can you talk about the performance for volume and maybe even ASV across given

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot